Brethaire
Brethaire (terbutaline sulfate) is a bronchodilator (beta-2 adrenergic receptor agonist) designed for oral inhalation. It works by relaxing muscles in the airways to improve breathing. Although the Brethaire brand has been discontinued in several markets, the active ingredient terbutaline remains widely used.
Dosage by Body Weight
The usual dosage for adults and children 12 years of age and older is 2 inhalations separated by a 60-second interval, repeated every 4 to 6 hours as needed. It is not routinely prescribed or dosed by body weight for infants and young children.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients below the age of 12 have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients below the age of 12 have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients below the age of 12 have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients below the age of 12 have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Consult a healthcare provider. Terbutaline inhalation is typically restricted to adults and children aged 12 and older.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients below the age of 12 have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients below the age of 12 have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients below the age of 12 have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients below the age of 12 have not been established. |
| 16-20 kg | Not recommended | N/A | Consult a healthcare provider. Terbutaline inhalation is typically restricted to adults and children aged 12 and older. |
Formulation
Purpose
Relief and prevention of bronchospasm in patients with asthma, chronic bronchitis, and emphysema.
Generic Name
Terbutaline sulfateScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.